Autoren

Matthew Royle, Ph.D.

Partner

Read More

Adrian Toutoungi

Partner

Read More

Paul England, DPhil

Senior Professional Support Lawyer

Read More
Autoren

Matthew Royle, Ph.D.

Partner

Read More

Adrian Toutoungi

Partner

Read More

Paul England, DPhil

Senior Professional Support Lawyer

Read More

27. Juli 2020 | 39:23

Dissecting the Regeneron v Kymab mouse case – what it says and its impact on patents

The Supreme Court's Regeneron Pharmaceuticals Inc v Kymab Ltd decision to revoke two patents for transgenic mouse technology has caused concern to biotech patent owners, especially since the Supreme Court expressed a need to rebalance patent law.

Has this case shifted the boundaries of patent protection, or merely clarified the status quo? What is its context, and broader impact on patents both within and outside the life sciences technology area?

Our experts explain the case and answer these questions in this webinar.

Call To Action Arrow Image

Newsletter-Anmeldung

Wählen Sie aus unserem Angebot Ihre Interessen aus!

Jetzt abonnieren
Jetzt abonnieren

Related Insights

pills
Patents Technology & Life Sciences

IP: Licensing and insolvency

23. Juli 2020
QUICK READ

von mehreren Autoren

Klicken Sie hier für Details
woman-with-scientific-model
Life Sciences & Healthcare

Everything biologic and biosimilar in-house counsel need to know about COVID-19

29. April 2020

von mehreren Autoren

Klicken Sie hier für Details
Life Sciences & Healthcare

The Bolar and related exemptions in Europe

What activity do they cover?

5. März 2020

von mehreren Autoren

Klicken Sie hier für Details

Events

Alle Veranstaltungen und Webinare finden Sie auf unserer Event-Seite.